Human Immunology News Volume 10.10 | Mar 15 2022

    0
    48







    2022-03-15 | HIN 10.10


    Human Immunology News by STEMCELL Technologies
    Vol. 10.10 – 15 March, 2022
    TOP STORY

    PD-1 Blockade with Pembrolizumab in Classic or Endemic Kaposi’s Sarcoma: A Multicentre, Single-Arm, Phase II Study

    Investigators evaluated the activity of pembrolizumab in classic and endemic Kaposi sarcoma with cutaneous extension requiring systemic treatment.
    [Lancet Oncology]

    Abstract
    Get up to 20% off on frozen human primary cell products.
    PUBLICATIONSRanked by the impact factor of the journal

    Human Epigenetic and Transcriptional T Cell Differentiation Atlas for Identifying Functional T Cell-Specific Enhancers

    Researchers generated an epigenetic and transcriptional atlas of T cell differentiation from healthy humans that included exhausted CD8 T cells and applied this resource in three ways.
    [Immunity]

    Abstract

    Mechanistic Convergence of the TIGIT and PD-1 Inhibitory Pathways Necessitates Co-Blockade to Optimize Anti-Tumor CD8+ T Cell Responses

    Although PD-1 and TIGIT were thought to regulate different costimulatory receptors, effectiveness of PD-1 or TIGIT inhibition in preclinical tumor models was reduced in the absence of CD226.
    [Immunity]

    Full ArticleGraphical Abstract

    Tumor-Derived Jagged1 Promotes Cancer Progression through Immune Evasion

    Scientists reported that tumor-derived Jagged1 is a key regulator of the tumor immune microenvironment. Jagged1 promoted tumorigenesis in multiple spontaneous mammary tumor models.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Immunosuppressive TREM2+ Macrophages Are Associated with Undesirable Prognosis and Responses to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer

    Large cohorts of non-small cell lung cancer patients from The Cancer Genome Atlas and a single-cell sequencing dataset were integrated to illustrate immunosuppressive phenotypes of tumor-associated macrophages, followed by experimental verification.
    [Cancer Immunology Immunotherapy]

    Abstract

    PRMT5 in T Cells Drives Th17 Responses, Mixed Granulocytic Inflammation, and Severe Allergic Airway Inflammation

    Researchers showed that PRMT5 drove allergic airway inflammation in a mouse model reproducing multiple aspects of human severe asthma.
    [Journal of Immunology]

    Abstract

    Comprehensive Analysis of Pyroptosis Regulation Patterns and Their Influence on Tumor Immune Microenvironment and Patient Prognosis in Glioma

    Pyroptosis regulation patterns were comprehensively evaluated on 33 pyroptosis-related genes in 1716 glioma samples. The correlations were analyzed between pyroptosis regulation patterns and tumor microenvironmentimmune cell infiltration properties.
    [Discover Oncology]

    Full Article

    The Impact of Opioid Exposure during Pregnancy on the Human Neonatal Immune Profile

    The authors compared immune cell populations, inflammatory and anti-inflammatory cytokine in the serum, and monocyte and T cell functional activity using umbilical cord samples from neonates with known opioid exposure during gestation and from control neonates without known exposure.
    [Pediatric Research]

    Full Article

    BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes

    Investigators demonstrated that BCOR and BCORL1 mutations in leukemia unlinked PRC1.1 repressive function from target genes, resulting in epigenetic reprogramming and activation of aberrant cell signaling programs that mediated treatment resistance.
    [Blood Cancer Discovery]

    Abstract
    Subscribe to the Immunology Podcast YouTube Channel
    REVIEWS

    Gut Microbiota-Derived Bile Acids in Intestinal Immunity, Inflammation, and Tumorigenesis

    The authors discuss recent studies on the involvement of gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis along with human omics data to provide prospective insights into future prevention and treatment of Inflammatory bowel disease and colorectal cancer.
    [Cell Host & Microbe]

    Abstract

    T Lymphocytes in Parkinson’s Disease

    Previous studies have shown that T cells play a key role both in the central nervous system and in the periphery, leading to a profound imbalance in the immune network of Parkinson’s Disease patients.
    [Journal of Parkinsons Disease]

    Full Article
    INDUSTRY AND POLICY NEWS

    PDS Biotech Announces Achievement of an Enrollment Objective in National Cancer Institute-Led Phase II Clinical Trial of PDS0101-Based Combination in Advanced HPV-Associated Cancers

    PDS Biotechnology Corporation announced that the National Cancer Institute achieved the intended enrollment objective in the Phase II clinical trial evaluating PDS0101 in combination with two investigational immune-modulating agents in advanced HPV-associated cancers.
    [PDS Biotechnology Corporation]

    Press Release

    Merck Announces KEYLYNK-010 Trial Evaluating KEYTRUDA® (Pembrolizumab) in Combination with LYNPARZA® (Olaparib) in Patients with Metastatic Castration-Resistant Prostate Cancer to Stop for Futility

    Merck announced that it will stop the Phase II KEYLYNK-010 trial investigating KEYTRUDA for the treatment of patients with metastatic castration-resistant prostate cancer who progressed after treatment with chemotherapy and either abiraterone acetate or enzalutamide.
    [Imugene]

    Press Release
    FEATURED EVENT

    EMBO Workshop: Pathogens Immunity and Signaling

    April 4 – 8, 2022
    Saint Malo, France

    > See All Events

    JOB OPPORTUNITIES

    Senior Associate Scientist – Biology

    Gilead Sciences – Foster City, California, United States

    Research Chair – Canada Excellence

    University of Sherbrooke – Sherbrooke, Quebec, Canada

    Postdoctoral Scientist – Liver Resident Memory T Cell

    Amsterdam UMC – Amsterdam, Netherlands

    Research Scientist – CAR T Cells

    BioNTech – Gaithersburg, Maryland, United States

    Postdoctoral Positions – Human Immunology and Inflammation

    National Institute for Health and Medical Research – Paris, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter